USPTO serial 79427536
EXORNEASY
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- TMO LAW OFFICE 122
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with EXORNEASY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological products for use in industry or research use, namely, reagents and substances for use in industry and science; chemical, biochemical and biotechnological products for non-medical purposes, namely, reagents and substances for use in industry and science; chemical, biochemical and biotechnological products for use in in-vitro-diagnostic for non-medical purposes, namely, in-vitro diagnostic reagents and substances for scientific and industrial purposes; chemical, biochemical and biotechnological products for use in scientific and laboratory research, namely, chemicals and preparations for use in industry and science; chemical, biochemical and biotechnological products for use in in-vitro diagnostic for scientific research or laboratory use, namely, in vitro diagnostic reagents and preparations for scientific purposes; chemical, biochemical and biotechnological reagents and preparations for use in scientific and laboratory research, namely chemicals for use in industry and science; kits comprising chemical, biochemical and biotechnological products, namely, substances, chemicals and preparations sold as kits for industrial and scientific purposes; kits comprising chemical, biochemical and biotechnological products, namely, diagnostic reagents and preparations sold as kits for use in in-vitro diagnostics for scientific, non-medical purposes; non-medical reagents, enzymes and chemicals, used in analytical chemistry, for scientific and medical research use for marking, separating, isolating, purification and for the analysis of biopolymers, in particular extracellular vesicles such as exosomes and their molecular constituents like proteins, lipids and nucleic acids, including DNA, RNA, mRNA, miRNA, in particular reagents, enzymes and buffer solutions for purification, isolation and analysis of extracellular vesicles and nucleic acids; chemical test kits comprising non-medical reagents, enzymes and buffer solutions for analysis for laboratory or research use for marking, separating, isolating and/or for the analysis of biopolymers, in particular extracellular vesicles such as exosomes and nucleic acids | ACTIVE | — |
| 005 | Chemical, biochemical and biotechnological products for medical and veterinary purposes, namely, in vitro diagnostic reagents and preparations for medical and veterinary diagnostic use; chemical, biochemical and biotechnological products for human in-vitro diagnostic purposes, namely, in vitro diagnostic reagents and preparations for medical use; chemical, biochemical and biotechnological reagents and preparations for human in-vitro diagnostic purposes, namely, in vitro diagnostic reagents and preparations for clinical use; kits comprising chemical, biochemical and biotechnological products for human in vitro diagnostic, namely, kits comprised of in vitro diagnostic reagents and preparations for medical use; chemical, biochemical and biotechnological products for medical and pharmaceutical research, namely, in vitro diagnostic reagents and preparations for medical analytic use; kits comprising chemical products for human in-vitro diagnostic for medical or pharmaceutical purposes, namely, kits comprised of in vitro diagnostic chemical reagents and preparations for medical use; kits comprising chemical, biochemical and biotechnological products for human in vitro diagnostic for detection of pathogens, viruses and bacteria for medical or pharmaceutical purposes, namely, kits comprised of in vitro diagnostic reagents and preparations for medical use; diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, purification and/or for the analysis of biopolymers, in particular extracellular vesicles such as exosomes and their molecular constituents like proteins, lipids and nucleic acids, including DNA, RNA, mRNA, miRNA; diagnostic reagents, enzymes and buffer solutions for purification isolation and analysis of extracellular vesicles and nucleic acid for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for marking, separating, isolating, purification and for the analysis of biopolymers, in particular extracellular vesicles and their molecular constituents like nucleic acids, proteins and lipids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, in particular for marking, separating, isolating, purification and for the analysis of biopolymers, in particular extracellular vesicles, nucleic acids, including DNA, RNA, mRNA, miRNA, proteins and lipids; diagnostic kits containing reagents, enzymes and buffer solutions for purification and isolation of extracellular vesicles and their molecular constituents and nucleic acid isolation, amplification and analysis for medical or veterinary purposes | ACTIVE | — |
| 009 | Laboratory apparatus and instruments, namely for spin-column-based sample preparation and analysis; scientific apparatuses, instruments and devices, as well as their parts and components, namely, spin columns, collection tubes, tubes, pipette tips for laboratory use, chromatographic columns for laboratory use; chromatography spin columns for laboratory use; membranes for filtration for scientific laboratory use in affinity and size exclusion chromatography (SEC); chromatography spin column membranes for laboratory use; bottles and vessels being glassware and plastic consumables for laboratory use; laboratory storage and collecting test tubes; holders adapted for test tubes; downloadable software for database management, process control, full connectivity and surveillance of laboratory apparatus and instruments, protocols for purification of extracellular vesicles, exosomes, RNA, DNA, such as extracellular DNA, genomic DNA, plasmid DNA, viral nucleic acids and proteins, DNA and RNA cleanup, for use in scientific and medical research; scientific apparatuses, instruments and devices, including disposable equipment, components and parts thereof, namely, tubes, pipette tips, chromatographic columns, chromatography spin columns, bottles and vessels being glassware and plastic consumables, all for laboratory use; laboratory storage and collecting test tubes for use in the purification, isolation and analysis of nucleic acids, including DNA, RNA, mRNA, miRNA, and extracellular vesicles, such as exosomes, and their molecular constituents like proteins, nucleic acids and lipids; scientific apparatuses, instruments and devices, including disposable equipment, components and parts thereof, namely, tubes, pipette tips, chromatographic columns, chromatography spin columns, bottles and vessels being glassware and plastic consumables, all for laboratory use; laboratory storage and collecting test tubes for use in analysis and determination of quality and quantity of vesicles; laboratory filters; membranes including ultrafiltration and adsorption membranes, all being laboratory filters for laboratory apparatus; filters for biological samples, including cell cultures and their supernatants, blood and blood components for laboratory use; scientific apparatuses, instruments and devices, including disposable equipment, components and parts thereof, namely, tubes, pipette tips, chromatographic columns, chromatography spin columns, bottles and vessels being glassware and plastic consumables, all for laboratory use; laboratory storage and collecting test tubes for use in purification, isolation and analysis of vesicles from biological samples, in particular biofluids, including urine, serum, plasma, cerebrospinal fluid (CSF) and cell culture supernatant | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 3, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 3, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 3, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 12, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 3, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 12, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 12, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 2, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 1, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 11, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 10, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |